P Zacharatos - Concepedia

Author

P Zacharatos

National and Kapodistrian University of Athens

Also Known As

G Masotti, P V Zacharatos, P Zacharatos, P. Zacharatos, PV Zacharatos, Panagiotis Zacharatos, Panayiotis Zacharatos

Publications

451

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Roy Castle Lung Cancer Foundation Laiko General Hospital of Athens University of Liverpool Baylor College of Medicine

About

P Zacharatos is an author at National and Kapodistrian University of Athens specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	218
2	Cell Biology	6	6	168
3	Immunology	2	2	20
4	Natural Sciences	1	1	21
5	Allergy	1	1	19

P Zacharatos

Publications

429

Citations

H-Index

Page 1

	Year	Citations
Multiplex polymerase chain reaction for the detection of mycobacterial DNA in cases of tuberculosis and sarcoidosis. John Ikonomopoulos, Vassilis G. Gorgoulis, P Zacharatos, PubMed	1999	60
MAPKs and NF-κB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress Ioanna Sigala, P Zacharatos, Dimitris Toumpanakis, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	2011	49
Electron microscopy evidence that cytoplasmic localization of the p16<sup>INK4A</sup>“nuclear” cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas Kostas Evangelou, John Bramis, I Peros, Biotechnic & Histochemistry PathologyTumor CellsCancer BiologyCytoplasmic LocalizationTumor Biology	2004	44
Alterations of p16-pRb Pathway and Chromosome Locus 9p21–22 in Sporadic Invasive Breast Carcinomas Vassilis G. Gorgoulis, Efthimia Koutroumbi, Athanasios Kotsinas, Molecular Medicine Breast OncologyCancer PathologyMedicineP16-prb PathwayCancer Cell Biology	1998	41
Altered Expression of the Cell Cycle Regulatory Molecules pRb, p53 and MDM2 Exert a Synergetic Effect on Tumor Growth and Chromosomal Instability in Non-small Cell Lung Carcinomas (NSCLCs) Vassilis G. Gorgoulis, P Zacharatos, Athanasios Kotsinas, Molecular Medicine	2000	40
Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. Vassilis G. Gorgoulis, P Zacharatos, G. Mariatos, PubMed P53 StatusTumor BiologyP53 AlterationsOncologyOncogenic Agent	2001	36
Association of allelic loss at the <i>FHIT</i> locus and <i>p53</i> alterations with tumour kinetics and chromosomal instability in non‐small cell lung carcinomas (NSCLCs) George A. Garinis, Vassilis G. Gorgoulis, George Mariatos, The Journal of Pathology	2000	27
Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression? Periklis Foukas, Vassilis Tsilivakos, P Zacharatos, PubMed	2001	24
Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene P Zacharatos, E N Manolis, Alexander Damalas, British Journal of Cancer Tumor BiologyOncologyOncogenic AgentMedicineP53-responsive Element	1998	23
Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene Athanassios Kotsinas, Vassilis G. Gorgoulis, P Zacharatos, Cancer Genetics and Cytogenetics Human H-ras GeneHexanucleotide Polymorphic SiteNatural SciencesGeneticsHuman Polymorphism	2001	21

Page 1